StockData
Creative Medical Technology Holdings, Inc. logo

Creative Medical Technology Holdings, Inc. (CELZ) stock

CELZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 7/30
$0.47−0.01 (-2.16%)

Close on Nov 18, 2026Market cap $3.07MP/E –Yield –

Creative Medical Technology free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

No free cash flow figures for Creative Medical Technology

Creative Medical Technology has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Creative Medical Technology figures

See a number that looks wrong?